NewKerala.com

Nagaland's Healthcare Boost: IPC Signs 3 MoUs to Strengthen Drug Safety

The Indian Pharmacopoeia Commission has taken a significant step toward strengthening healthcare in Nagaland. They've signed three important agreements with key medical organizations in the state. These partnerships focus on improving drug safety monitoring and adverse event reporting systems. The initiative represents a major advancement in patient safety measures for the northeastern region.

Key Points: IPC Signs MoUs with Nagaland for Pharmacovigilance Enhancement

  • IPC signs first-ever MoU with Nagaland Medical Council for patient safety
  • Collaboration aims to expand adverse drug reaction monitoring centers nationwide
  • Initiative promotes mandatory use of National Formulary of India for safe medication
  • Three MoUs signed during training program on pharmacovigilance practices
3 min read

IPC signs 3 MoUs to strengthen pharmacovigilance, materiovigilance in Nagaland

Indian Pharmacopoeia Commission partners with Nagaland agencies to strengthen drug safety monitoring, adverse event reporting, and promote rational medicine use across healthcare facilities.

"IPC is committed to providing all possible technical guidance and expert support for these initiatives - Ministry of Health"

New Delhi, Nov 28

The Indian Pharmacopoeia Commission (IPC), Ghaziabad, has signed three Memoranda of Understanding (MoU) with the Nagaland Medical Council, the Nagaland State Drugs Control Administration (NSDCA), Department of Health & Family Welfare, Nagaland, and the State Pharmacy Council, Government of Nagaland, the Ministry of Health said on Friday.

The MoUs were signed during the one-day training programme on pharmacovigilance and materiovigilance organised by IPC in collaboration with NSDCA.

“The collaboration seeks to strengthen pharmacovigilance and materiovigilance, promote adverse event reporting, build stakeholder capacity, expand adverse drug reaction (ADR) monitoring centres/ Medical Device Adverse Event Monitoring Centres (MDMCs), and advance safe medicine use through the National Formulary of India across healthcare facilities in Nagaland,” the Ministry said.

Notably, the MoU with Nagaland Drugs Control Administration is IPC’s second MoU, followed by UPFDA, and the first of its kind in the North Eastern region.

The MoU with the Nagaland Medical Council is the first MoU with any State Medical Council in the country for the promotion of the Pharmacovigilance Programme of India and Materiovigilance Programme of India, aimed to promote patient safety up to the level of primary health centres in the country.

The MoU with the State Pharmacy Council is the fourth state pharmacy council in the country to sign an MoU for safe and rational use of medicines, enhancing pharmacovigilance and materiovigilance activities, and advancing patient safety initiatives.

Through these MoUs, the IPC is committed to working together with all three organisations, NSDCA, and the Nagaland State Pharmacy Council and Nagaland Medical Council to strengthen pharmacovigilance and materiovigilance activities. It will also promote adverse events reporting with the use of drugs/medical devices and utilise the National Formulary of India (NFI) as a standard reference document across healthcare facilities in Nagaland, supporting rational dispensing and safe medication practices, the Ministry said.

In addition, the MoUs aim to promote capacity building to all stakeholders, including healthcare professionals (physicians, pharmacists, nurses, etc) involved in pharmacovigilance and materiovigilance practices, scientific personnel involved in quality control of medical products, and safe use of medicines through mandatory use of the National Formulary of India.

"IPC is committed to providing all possible technical guidance and expert support for these initiatives, while NSDCA and Nagaland State Pharmacy Council will coordinate with medical colleges/hospitals/pharmacists/drugs inspectors/industry stakeholders, and other healthcare professionals in both public and private healthcare establishments to ensure effective implementation of the agreed activities," the Ministry said.

- IANS

Share this article:

Reader Comments

P
Priya S
As someone who works in healthcare, I appreciate the focus on pharmacovigilance. Many adverse drug reactions go unreported in India. This collaboration with Nagaland Medical Council is a step in the right direction for patient safety across the country.
A
Arjun K
Great to see government initiatives reaching the North East states! The MoU with State Pharmacy Council for rational use of medicines is particularly important. Hope they implement this properly and don't let it remain just on paper 🤞
S
Sarah B
While this sounds promising, I hope they allocate sufficient funds and create proper monitoring mechanisms. Too many MoUs get signed but implementation remains weak. The success will depend on how well they train healthcare workers at ground level.
V
Vikram M
Excellent move! The National Formulary of India as standard reference will bring much-needed standardization in prescription practices. This should be implemented across all states to ensure uniform healthcare quality nationwide.
M
Michael C
Good to see India strengthening its drug safety monitoring systems. The materiovigilance program for medical devices is particularly important as India expands its medical device manufacturing. Hope this leads to better patient outcomes! 👍

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50